Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia

PURPOSE: Despite the established role of imatinib (IM) in chronic myelogenous leukemia (CML) in adults, there are few reports on its efficacy in children. In this study, we compared the outcomes of children with CML before and after the advent of IM-based treatment. METHODS: The study cohort consist...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Hyun Jin, Cho, Mun Sung, Lee, Jae Wook, Jang, Pil-Sang, Chung, Nack-Gyun, Cho, Bin, Kim, Hack-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pediatric Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764259/
https://www.ncbi.nlm.nih.gov/pubmed/24019845
http://dx.doi.org/10.3345/kjp.2013.56.8.343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764259/
https://www.ncbi.nlm.nih.gov/pubmed/24019845
http://dx.doi.org/10.3345/kjp.2013.56.8.343

Ejemplares similares